Relevant bibliographies by topics / Senile dementia Treatment Australia

Academic literature on the topic 'Senile dementia Treatment Australia'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Senile dementia Treatment Australia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Senile dementia Treatment Australia"

1

Stout, I. H. "Treatment of pre-senile dementia patients." Bulletin of the Royal College of Psychiatrists 11, no. 9 (September 1987): 312–13. http://dx.doi.org/10.1192/s0140078900017909.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bruyn, G. W. "Diagnosis and treatment of senile dementia." Journal of the Neurological Sciences 95, no. 2 (February 1990): 235. http://dx.doi.org/10.1016/0022-510x(90)90249-m.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stout, I. H. "Treatment of pre-senile dementia patients." Psychiatric Bulletin 11, no. 9 (September 1, 1987): 312–13. http://dx.doi.org/10.1192/pb.11.9.312-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Grossmann, W., A. Standl, U. May, H. van Laak, and H. Hirche. "Naftidrofuryl in the Treatment of Mild Senile Dementia." Pharmacopsychiatry 23, no. 06 (November 1990): 265–73. http://dx.doi.org/10.1055/s-2007-1014517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Markstein, R. "Pharmacological Approaches in the Treatment of Senile Dementia." European Neurology 29, no. 3 (1989): 33–41. http://dx.doi.org/10.1159/000116479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Steiger, William A., Marilyn Mendelson, Terry Jenkins, Marie Smith, and Ruth Gay. "Effects of Naloxone in Treatment of Senile Dementia." Journal of the American Geriatrics Society 33, no. 2 (February 1985): 155. http://dx.doi.org/10.1111/j.1532-5415.1985.tb02286.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Honjo, H., M. Urabe, K. Iwasa, T. Okubo, H. Tsuchiya, N. Kikuchi, M. Hayashi, and K. Hayashi. "A47 Estrogen treatment for senile dementia-Alzheimer's type." Maturitas 27 (November 1996): 15. http://dx.doi.org/10.1016/s0378-5122(97)80884-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sarter, Martin, Herbert H. Schneider, and David N. Stephens. "Treatment strategies for senile dementia: antagonist β-carbolines." Trends in Neurosciences 11, no. 1 (January 1988): 13–17. http://dx.doi.org/10.1016/0166-2236(88)90042-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yi, W. Jian, D. Sinbon, P. Shuching, and L. Bolan. "Ginkgo biloba in the treatment of senile dementia." European Neuropsychopharmacology 6 (June 1996): 187. http://dx.doi.org/10.1016/0924-977x(96)88178-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

CHENG, Hai-ying, and Dong-qi CHENG. "Progress in Research on Acupuncture Treatment of Senile Dementia." Journal of Traditional Chinese Medicine 29, no. 3 (September 2009): 224–33. http://dx.doi.org/10.1016/s0254-6272(09)60071-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Senile dementia Treatment Australia"

1

黃子強. "中醫藥膳食療在癡呆症方面的應用." HKBU Institutional Repository, 2012. http://repository.hkbu.edu.hk/etd_ra/1351.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Matthews, Ernest A. "The effect of 'environmental manipulation' on agitation and 24-hour sleep in dementia sufferers in an institutional setting." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 1993. https://ro.ecu.edu.au/theses/1146.

Full text
Abstract:
Living in an institutional setting places on residents certain constraints in relation to freedom of choice as to when, where, and how they conduct activities of daily living, such as, sleeping eating, attending to hygiene needs. Studies indicate this loss of control over the environment contributes to loss of self-esteem, leads to stress, and at times precipitates agitation among nursing home residents. Cognitive impairment may render dementia sufferers more vulnerable to loss of control over their control over their environment and result in agitation, which may in turn influence sleep. The study therefore, investigated if ‘environmental manipulation’ as in introducing flexibility in place of strict time schedules affected agitation and 24-hour sleep in 33 institutionalised dementia sufferers. The Cohen-Mansfield Agitation Inventory (CMAI) and the sleep scale included in the Dementia Mood Assessment Scale were used to quantify agitation and 24-hour sleep respectively. A ‘within-subject’ longitudinal time design comprising 4 phases was used with each phases was used with each phase covering 4 weeks. ‘Environmental manipulation’ was introduced following phase 2. Agitation was examined under 4 categories: aggressive, non-aggressive, verbally agitated, and ‘other agitated’ behaviours. A significant reduction in verbal agitation and a significant increase in ‘other agitated’ behaviours were observed on the early nursing shift. Descriptive statistics indicated a reduction in total agitated behaviours following the intervention on the early shift. Although 24-hour sleep as well as day sleep increased significantly immediately following the intervention, they returned to pre-intervention levels in phase 4. Night sleep was not affected. Findings of the study are of considerable clinical significance as there are few empirically validated nursing interventions to manage agitation and fragmented sleep in dementia sufferers.
APA, Harvard, Vancouver, ISO, and other styles
3

Wilkinson, Peter. "De concentv amisso qvaerendo: An investigation into the relative benefits of three different types of ambient music on the observed agitated behaviour and quality of life of dementia sufferers in residential aged care facilities." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2014. https://ro.ecu.edu.au/theses/1562.

Full text
Abstract:
There is an increasing body of research evidence to support the use of music as a therapeutic modality in reducing the agitated behaviour frequently associated with late-stage dementia. Although much of this evidence suggests that music interventions are most effective when they are “individualized”, this type of intervention is often difficult to implement in large, busy, aged care facilities where residents may be located together in communal areas during the day. The challenge therefore is to try and identify a particular musical genre which, when played as “ambient” or “background” music, demonstrates a consistent capacity to reduce agitated behaviour in late-stage dementia across resident populations in multiple facilities. This study was designed to test the comparative utility of three different types of background music identified in the existing research literature as being of possible benefit in this context. These three types of music were: gentle classical music, familiar music and baroque music. Using a sample of 65 older people with late-stage dementia living in a total of eight residential aged care facilities, this quasi-experimental study used quantitative measures to assess a specific range of agitated behaviours over a one week intervention period. The specific agitated behaviours were documented using the Scale for the Observation of Agitation in Persons with Dementia (SOAP-D) scale (Hurley, Volicer, Camberg, Ashley, Woods, Odenheimer, Ooi, McIntyre, & Mahoney, 1999). In addition, the Quality of Life in Alzheimer’s Disease (QoL-AD) tool (Logsdon, 1999) was used to collect collateral information from family members or experienced care staff at each of the participating facilities about whether they perceived that the playing of music exerted any influence on the quality of life of participants. Participants were randomly assigned to one of five experimental subgroups of equal size. Participants in three of the five groups received exposure to audio recordings of music. Participants in one of the two remaining sub-groups were exposed to a non-musical intervention (audio recordings of storybooks) at the same time of day as the participants in the three music groups. Data relating to behaviour and perceived quality of life were recorded in the same manner for this group. The final group of participants acted as the control group for the study. Quantitative data were collected in the same manner for this group: however, they were exposed to no intervention. In addition, a series of structured interviews was undertaken with experienced care providers at each of the participating residential aged care facilities. The purpose of this procedure was to determine whether the experiences and subjective opinions of staff regarding the utility of music as an intervention to settle agitated behaviour in late-stage dementia and improve quality of life were consistent with the observational data recorded using the SOAP-D scale in conjunction with the proxy-rated QoL-AD scale. Results of the study indicated that overall levels of agitated behaviour were less within the three groups exposed to music compared with the nonmusic intervention group and the control. However, perceived quality of life was not measurably improved in any of the three music intervention groups. This study supports the continued use of music as a therapeutic intervention in the management of maladaptive behaviour associated with late-stage dementia, although the results do not support the preferential use of any of the three selected music forms.
APA, Harvard, Vancouver, ISO, and other styles
4

許美蓮. "補氣化痰袪瘀方藥治療老年癡呆的文獻回顧分析." HKBU Institutional Repository, 2008. http://repository.hkbu.edu.hk/etd_ra/977.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baldwin, P. Clive. "Narrative, ethics and severe mental illness." 2005. http://hdl.handle.net/10454/3268.

Full text
Abstract:
No
Starting from the premise that people are essentially narrative beings, I argue that the onset of severe mental illness compromises the narrative enterprise of being able to construct one's Self and one's relationships inmeaningful and coherent ways. This is due to both the curtailment of opportunities for narrative engagement and the dispossession of those whose narratives do not conform to the current conceptualization of narrative and narrativity. In these circumstances, supporting the narrative enterprise is an ethical endeavour that requires that we examine not only which narratives we construct, but also how we construct them. This requires a re-thinking of what might constitute narrative and how we might facilitate or enhance the narrativity of people with severe mental illness. Following this, I suggest four means to support the narrativity of people with severe mental illness: through maintaining narrative continuity, maintaining narrative agency, countering master narratives and attention to small stories.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Senile dementia Treatment Australia"

1

Keen, Justin. Dementia. London: Office of Health Economics, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Keen, Justin. Dementia. London: Office of Health Economics, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bergener, Manfred, and Barry Reisberg, eds. Diagnosis and Treatment of Senile Dementia. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Australian Institute of Health and Welfare. Dementia in Australia: National data analysis and development. Canberra: Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Madsen, Per A. Senility according to the readings of Edgar Cayce. Virginia Beach, VA: Edgar Cayce Foundation, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Conroy, M. Catherine. Dementia care: Keeping intact and in touch : a search for occupational therapy interventions. Aldershot, Hants, England: Avebury, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

A, Ban Thomas, and Lehmann Heinz E. 1911-, eds. Diagnosis and treatment of old age dementias: Symposium on Diagnosis and Treatment of Old Age Dementias, Milan, June 6, 1987. Basel: Karger, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dementia in later life: Research and action : report of a WHO Scientific Group on Senile Dementia. Geneva: World Health Organization, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wo men dou hui lao: Ru he zhao gu lao ren chi dai zheng. Taibei Shi: Hua zhi wen hua shi ye you xian gong si, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Đsong, Thịnh. Chtan đoán, phòng và điseu trị chwung ltan thtan yo ngưxoi cao tutoi. Hà Nuoi: NXB Y học, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Senile dementia Treatment Australia"

1

Fischhof, P. K., G. Wagner, L. Littschauer, E. Rüther, M. Apecechea, R. Hiersemenzel, J. Röhmel, F. Hoffmeister, and N. Schmage. "Therapeutic Results with Nimodipine in Primary Degenerative Dementia and Multi-Infarct Dementia." In Diagnosis and Treatment of Senile Dementia, 350–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Whitehouse, P. J., J. R. Unnerstall, M. Tabaton, and D. J. Lanska. "Neurochemistry of Dementia: Clinical Pathological Relationships." In Diagnosis and Treatment of Senile Dementia, 54–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baumel, B., L. S. Eisner, M. Karukin, R. MacNamara, and H. Raphan. "Nimodipine in the Treatment of Alzheimer’s Disease." In Diagnosis and Treatment of Senile Dementia, 366–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bergener, M. "Future of Psychogeriatrics: A Multidisciplinary Approach with Applications for Clinical Practice." In Diagnosis and Treatment of Senile Dementia, 3–13. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jenike, M. A. "Affective Disorders in Elderly and Dementing Patients." In Diagnosis and Treatment of Senile Dementia, 90–125. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Poon, L. W. "Psychological and Cognitive Factors in Psychogeriatric Memory Assessment." In Diagnosis and Treatment of Senile Dementia, 129–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kranzhoff, E. U. "Essentials of Psychological Assessment of the Mentally Ill Elderly: Mild Cognitive Impairment and the Issue of Plasticity." In Diagnosis and Treatment of Senile Dementia, 142–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Janke, W., and M. Hüppe. "Psychological Methods for the Assessment of Performance and Emotionality in Elderly Patients." In Diagnosis and Treatment of Senile Dementia, 149–63. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Erzigkeit, H. "The SKT — A Short Cognitive Performance Test as an Instrument for the Assessment of Clinical Efficacy of Cognition Enhancers." In Diagnosis and Treatment of Senile Dementia, 164–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Guterman, A., and C. Eisdorfer. "Early Diagnosis of Dementias." In Diagnosis and Treatment of Senile Dementia, 177–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-46658-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Senile dementia Treatment Australia"

1

Requião, Letícia Escorse, Giulia Freitas, Mayanna Macedo, Hanny Gondim, Blenda Antunes, and Bruno Lopes. "Monoclonal antibodies: a new trend for the treatment of Alzheimer’s disease?" In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.439.

Full text
Abstract:
Introduction: Alzheimer’s disease (AD) is the main form of senile dementia. Most of the supposedly disease-modifying treatments in development are directed against the β-amyloid peptide, the administration of exogenous anti-Aβ monoclonal antibodies is a passive immunization strategy aimed at resolving the aggregation of this substance. Objective: Analyze the effectiveness of monoclonal antibodies in the treatment of Alzheimer’s disease. Methods: This is a literature review, based on randomized clinical trials published between 2014 and 2021. The search was conducted in the PubMed database. Results: According to the eligibility criteria, 10 articles were selected. Two of the randomized, double-blind, placebo-controlled phase III studies, one published in 2018 and the other published in 2016, evaluated the intervention with Solanezumab and Bapineuzumab, respectively. Both were not shown to be statistically significant (P = 0.10) for the outcome improvement of the score in the cognitive subscale of 14 and 11 items “Alzheimer’s Disease Assessment Scale” (ADAS-cog14 / 11). However, in a phase II randomized placebo-controlled clinical trial, published in 2021, the use of Donanemab in patients with early Alzheimer’s disease resulted in statistically significant cognitive and functional improvement (P = 0.04) for the outcome change in the scale “Integrated Alzheimer’s Disease Rating” (iADR). Conclusion: Although the use of Donanemab has resulted in cognitive and functional improvement, randomized, double-blind, placebo-controlled, phase III clinical trials need to be conducted to prove the efficacy and safety of its use in clinical practice. Other monoclonal antibodies evaluated did not demonstrate evidence of benefit.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Senile dementia Treatment Australia' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography